Autolus Therapeutics (AUTL) Change in Acquisitions & Divestments (2025)
Autolus Therapeutics posted quarterly Change in Acquisitions & Divestments of $126.0 million for Q4 2025, down 3.77% on a QoQ basis from $131.0 million in Q3 2025.
Autolus Therapeutics (AUTL) has 1 years of Change in Acquisitions & Divestments data on file, last reported at $126.0 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Acquisitions & Divestments changed N/A year-over-year to $126.0 million; the trailing twelve-month figure through Dec 2025 stood at $428.2 million (changed N/A YoY), and the FY2025 full-year result was $428.2 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments for Q4 2025 stood at $126.0 million, down from $131.0 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $151.2 million in Q2 2025 and bottomed at $20.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 126.04 Mn |
| Dec 31, 2025 | 126.04 Mn |
| Sep 30, 2025 | 130.98 Mn |
| Sep 30, 2025 | 130.98 Mn |
| Jun 30, 2025 | 151.19 Mn |
| Jun 30, 2025 | 151.19 Mn |
| Mar 31, 2025 | 20.00 Mn |
| Mar 31, 2025 | 20.00 Mn |